| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1971) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C05AA11 |
| UNII: | 2W4A77YPAN |
| InChI Key | WJOHZNCJWYWUJD-IUGZLZTKSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C26H32F2O7 |
| Molecular Weight | 494.53 |
| AlogP | 2.94 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 99.13 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 35.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Glucocorticoid receptor agonist | PubMed |
| Primary Target | |
|---|---|
| Glucocorticoid receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 120 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Skin Diseases | 4 | D012871 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Dermatitis, Atopic | 2 | D003876 | ClinicalTrials |
| Psoriasis | 0 | D011565 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 356-12-7 |
| ChEBI | 5109 |
| ChEMBL | CHEMBL1501 |
| DrugBank | DB01047 |
| DrugCentral | 1205 |
| EPA CompTox | DTXSID8045307 |
| FDA SRS | 2W4A77YPAN |
| Human Metabolome Database | HMDB0015181 |
| Guide to Pharmacology | 7078 |
| PharmGKB | PA449664 |
| PubChem | 9642 |
| SureChEMBL | SCHEMBL4262 |
| ZINC | ZINC000003977978 |